Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products pricing, coverage and access in Medicare and Medicaid; Issues related to funding for HIV and HCV screening, linkage to care and treatment; Issues related to breast cancer screening.
Source-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 18, 2026
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- FORBES-TATE
- Client
- GILEAD SCIENCES, INC.
- Filing UUID
- d5417963-e54e-4057-a62b-4902e756023e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.